Pharmaceutical industry needs - certainty' on post-Brexit regulations, MPs told


Failure to complete the first phase of Brexit negotiations is costing UK pharmaceutical companies "an enormous amount of money", industry representatives have warned. With less than 18 months to go until the official date of EU withdrawal in March 2019, companies are having to make preparations now, with some setting up facilities and offices abroad at a cost of tens of millions of pounds, MPs were told.



from Biotech News